Briacell announces availability of annual general meeting materials and alternative voting procedures

Philadelphia and vancouver, british columbia, dec. 17, 2024 (globe newswire) -- briacell therapeutics corp. (nasdaq: bctx, bctxw) (tsx: bct) (“briacell” or the “company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces that the company will be relying on, and has satisfied all of the conditions to rely on, csa coordinated blanket order 51-931 for exemption from the requirements to send proxy-related materials (the "meeting materials") for its upcoming annual general meeting (the "meeting") to be held on thursday, january 23, 2025, at suite 3400, one first canadian place, toronto, on, m5x 1a4. at 10:00 a.m. (est) due to the suspension of mail service in canada from the nationwide strike of the canadian union of postal workers that commenced on november 15, 2024.
GM Ratings Summary
GM Quant Ranking